Profil
Elissa S.
Cote is Chief Corporate Development Officer at Vistagen Therapeutics, Inc. since 2025.
Formerly, Ms. Cote was Vice President-Marketing & External Relations at Histogenics Corp.
Ms. Cote was Senior Vice President-Global Strategic Marketing at Sucampo Pharmaceuticals LLC from 2015 to 2018.
Ms. Cote completed undergraduate studies at Union College (New York).
Aktiva positioner av Elissa Cote
| Företag | Position | Start |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Företagsledare/Principal | 2025-06-23 |
Tidigare kända positioner av Elissa Cote
| Företag | Position | Slut |
|---|---|---|
| SUCAMPO PHARMACEUTICALS, INC. | Försäljning & Marknadsföring | 2018-02-01 |
| OCUGEN, INC. | Försäljning & Marknadsföring | - |
Elissa Cotes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Histogenics Corp.
Histogenics Corp. BiotechnologyHealth Technology Develops and commercializes regenerative medicine | Health Technology |
Union College (New York)
Union College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
VistaGen Therapeutics, Inc.
VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
















